The identification of deregulated microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) in multiple myeloma (MM) has progressively added a further level of complexity to MM biology. In addition, the cross-regulation between lncRNAs and miRNAs has begun to emerge, and theoretical and experimental studies have demonstrated the competing endogenous RNA (ceRNA) activity of lncRNAs as natural miRNA decoys in pathophysiological conditions, including cancer. Currently, information concerning lncRNA and miRNA interplay in MM is virtually absent. Herein, we investigated in silico the lncRNA and miRNA relationship in a representative datasets encompassing 95 MM and 30 plasma cell leukemia patients at diagnosis and in four normal controls, whose expre...
Simple Summary Multiple myeloma (MM), the second most common hematological neoplasm, is still consid...
Multiple myeloma (MM) is an incurable disease caused by the malignant proliferation of bone marrow p...
Simple Summary Multiple myeloma (MM), the second most common hematological neoplasm, is still consid...
The identification of deregulated microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) in multiple ...
The identification of overexpressed miRNAs in multiple myeloma (MM) has progressively added a furthe...
Microarray analysis of the multiple myeloma (MM) miRNome has unraveled the differential expression o...
To date, little evidence of miRNA expression/deregulation in multiple myeloma has been reported. To ...
To date, little evidence of miRNA expression/deregulation in multiple myeloma has been reported. To ...
To date, little evidence of miRNA expression/deregulation in multiple myeloma has been reported. To ...
The identification of overexpressed miRNAs in multiple myeloma (MM) has progressively added a furthe...
The role of microRNAs (miRNAs) in multiple myeloma (MM) remainsto be fully elucidated. To identify m...
The role of microRNAs (miRNAs) in multiple myeloma (MM) remainsto be fully elucidated. To identify m...
Multiple myeloma (MM) is an hematological neoplasm characterized by uncontrolled clonal proliferatio...
Multiple myeloma (MM) is an hematological neoplasm characterized by uncontrolled clonal proliferatio...
Background: The role of microRNAs (miRNAs) in multiple myeloma (MM) has yet to be fully elucidated. ...
Simple Summary Multiple myeloma (MM), the second most common hematological neoplasm, is still consid...
Multiple myeloma (MM) is an incurable disease caused by the malignant proliferation of bone marrow p...
Simple Summary Multiple myeloma (MM), the second most common hematological neoplasm, is still consid...
The identification of deregulated microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) in multiple ...
The identification of overexpressed miRNAs in multiple myeloma (MM) has progressively added a furthe...
Microarray analysis of the multiple myeloma (MM) miRNome has unraveled the differential expression o...
To date, little evidence of miRNA expression/deregulation in multiple myeloma has been reported. To ...
To date, little evidence of miRNA expression/deregulation in multiple myeloma has been reported. To ...
To date, little evidence of miRNA expression/deregulation in multiple myeloma has been reported. To ...
The identification of overexpressed miRNAs in multiple myeloma (MM) has progressively added a furthe...
The role of microRNAs (miRNAs) in multiple myeloma (MM) remainsto be fully elucidated. To identify m...
The role of microRNAs (miRNAs) in multiple myeloma (MM) remainsto be fully elucidated. To identify m...
Multiple myeloma (MM) is an hematological neoplasm characterized by uncontrolled clonal proliferatio...
Multiple myeloma (MM) is an hematological neoplasm characterized by uncontrolled clonal proliferatio...
Background: The role of microRNAs (miRNAs) in multiple myeloma (MM) has yet to be fully elucidated. ...
Simple Summary Multiple myeloma (MM), the second most common hematological neoplasm, is still consid...
Multiple myeloma (MM) is an incurable disease caused by the malignant proliferation of bone marrow p...
Simple Summary Multiple myeloma (MM), the second most common hematological neoplasm, is still consid...